These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19270818)

  • 21. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
    Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
    J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes].
    Li MW; Wang XP; Gao CY; Zou AR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):165-8. PubMed ID: 19719998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action.
    Kushida S; Ogura T; Komuro I; Nakaya H
    Eur J Pharmacol; 2002 Dec; 457(1):19-27. PubMed ID: 12460639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.
    Steidl JV; Yool AJ
    Biophys J; 2001 Nov; 81(5):2606-13. PubMed ID: 11606274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propafenone modulates potassium channel activities of vascular smooth muscle from rat portal veins.
    Cogolludo AL; Pérez-Vizcaíno F; López-López G; Ibarra M; Zaragozá-Arnáez F; Tamargo J
    J Pharmacol Exp Ther; 2001 Nov; 299(2):801-10. PubMed ID: 11602697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propafenone blocks ATP-sensitive K+ channels in rabbit atrial and ventricular cardiomyocytes.
    Christé G; Tebbakh H; Simurdová M; Forrat R; Simurda J
    Eur J Pharmacol; 1999 Jun; 373(2-3):223-32. PubMed ID: 10414443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes.
    Waldegger S; Niemeyer G; Mörike K; Wagner CA; Suessbrich H; Busch AE; Lang F; Eichelbaum M
    Cell Physiol Biochem; 1999; 9(2):81-9. PubMed ID: 10394001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K+ activation of kir3.1/kir3.4 and kv1.4 K+ channels is regulated by extracellular charges.
    Claydon TW; Makary SY; Dibb KM; Boyett MR
    Biophys J; 2004 Oct; 87(4):2407-18. PubMed ID: 15454439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium channel blocking properties of propafenone in rabbit atrial myocytes.
    Duan D; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1113-23. PubMed ID: 8450455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rg3 inhibits human Kv1.4 channel currents by interacting with the Lys531 residue.
    Lee JH; Lee BH; Choi SH; Yoon IS; Pyo MK; Shin TJ; Choi WS; Lim Y; Rhim H; Won KH; Lim YW; Choe H; Kim DH; Kim YI; Nah SY
    Mol Pharmacol; 2008 Mar; 73(3):619-26. PubMed ID: 17959711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking characteristics of hKv1.5 and hKv4.3/hKChIP2.2 after administration of the novel antiarrhythmic compound AZD7009.
    Persson F; Carlsson L; Duker G; Jacobson I
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):7-17. PubMed ID: 15965349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
    Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
    Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sensitivity of voltage-gated potassium channels Kv1.5 and Kv1.2 to acidic pH and molecular identification of pH sensor.
    Steidl JV; Yool AJ
    Mol Pharmacol; 1999 May; 55(5):812-20. PubMed ID: 10220559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide.
    Seyler C; Li J; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2014 Feb; 724():51-7. PubMed ID: 24374008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
    Castle NA; Fadous S; Logothetis DE; Wang GK
    Mol Pharmacol; 1994 Jun; 45(6):1242-52. PubMed ID: 8022416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of ginsenoside Rg(3) on human Kv1.4 channel currents without the N-terminal rapid inactivation domain.
    Lee JH; Choi SH; Lee BH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Bae DH; Rhim H; Nah SY
    Biol Pharm Bull; 2009 Apr; 32(4):614-8. PubMed ID: 19336893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of Xenopus Kv1.10 channels expressed in HEK293 cells.
    Fry M; Maue RA; Moody-Corbett F
    J Neurobiol; 2004 Aug; 60(2):227-35. PubMed ID: 15266653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.